Document is current
Any future updates will be listed below
-
Authors
Blake, Andrew D. http://orcid.org/0000-0002-2672-1354
Chao, Jianhua
SantaMaria, Anna M. http://orcid.org/0000-0001-8735-0721
Ekaputri, Stella
Green, Kelsie J.
Brown, Samantha T.
Rakowski, Christopher K.
Choi, Eun-Kyung
Aring, Luisa http://orcid.org/0000-0002-0437-4785
Chen, Peng-Jui http://orcid.org/0000-0002-3594-0081
Snead, Nicholas M.
Matje, Douglas M.
Geng, Tao
Octaviani, Angela
Bailey, Keith
Hollenbach, Stanley J.
Fan, Timothy M. http://orcid.org/0000-0003-2510-7050
Seo, Young-Ah http://orcid.org/0000-0003-3884-0665
Burke, Martin D. http://orcid.org/0000-0001-7963-7140
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01HL140526, R35GM118185, R35GM118185, R01HL140526, R01HL140526, R35GM118185, R35GM118185, R35GM118185, R01HL140526, R35GM118185, R01HL140526, T32GM070421, R35GM118185, R01HL140526, R01HL140526, R01HL140526)
- License Information
-
More Information
Article History
Received: 16 June 2022
Accepted: 1 March 2024
First Online: 25 April 2024
Competing interests
: M.D.B. is an inventor on the US patent application pub. 20180263926, ‘Restoring Physiology in Iron-Deficient Organisms Using Small Molecules’, which is directed to the use of small-molecule iron transporters to treat deficiencies of iron-transport proteins. A.D.B., A.M.S.M. and M.D.B. are inventors on the US patent application pub. 20210163393, ‘Hinokitiol analogs, methods of preparing and pharmaceutical compositions thereof’, which is directed to analogs of hinokitiol, preparation and formulation. These patent applications, their foreign counterparts and others have been licensed by Cajal Neuroscience, for which M.D.B. is a scientific advisor and shareholder. Ambys Medicines has filed patent applications directed to tropolone derivatives and tautomers thereof for iron regulation in animals. J.C., N.M.S., D.M.M., T.G., A.O. and S.J.H. were full-time employees of Ambys Medicines when these data were generated. These patents are currently owned by Cajal Neuroscience. The other authors declare no competing interests.
